Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
BACKGROUND: There are few data on predictors of HIV progression in untreated children in resource-limited settings. METHODS: Children with HIV Antibiotic Prophylaxis (CHAP) was a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected Zambian children. The prognostic value...
المؤلفون الرئيسيون: | Walker, A, Mulenga, V, Sinyinza, F, Lishimpi, K, Nunn, A, Chintu, C, Gibb, D |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2006
|
مواد مشابهة
-
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
حسب: Chintu, C, وآخرون
منشور في: (2004) -
The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
حسب: Walker, A, وآخرون
منشور في: (2007) -
Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.
حسب: Walker, A, وآخرون
منشور في: (2009) -
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
حسب: Haberer, J, وآخرون
منشور في: (2011) -
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.
حسب: Jessica E Haberer, وآخرون
منشور في: (2011-04-01)